<DOC>
	<DOCNO>NCT02581670</DOCNO>
	<brief_summary>Investigators design phase II study evaluate safety efficacy lung liver stereotactic radiation therapy ( SRT ) oligometastatic breast cancer patient unsuitable surgery , use VMAT RapidArc approach .</brief_summary>
	<brief_title>Study SBRT Inoperable Lung Liver Oligometastases From Breast Cancer</brief_title>
	<detailed_description>Investigators design prospective phase II study evaluate safety efficacy lung liver stereotactic radiation therapy ( SRT ) schedule oligometastatic breast cancer patient unsuitable surgery age major 18 year old adequate performance status ( ECOG ) , use VMAT RapidArc approach . The potential advantage technique ability deliver selective irradiation tumour 's target reduce dos normal tissue , optimize therapeutic window .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Patients age &gt; 18 year ECOG 02 Diagnosis Breast Cancer DFI ( Diseasefree interval ) &gt; 1 year No extrapulmonary and/or extrahepatic disease metastatic site stable respond chemotherapy No life threaten condition Lung liver lesion &lt; 5 ( maximum diameter &lt; 5 cm ) Chemotherapy complete least 3 week treatment Chemotherapy start least 2 week treatment allow Systemic therapy chemotherapy allow ( i.e hormonal therapy and/or immunotherapy ) Written informed consent ECOG &gt; 2 Pregnant woman Patients inability consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>oligometastatic breast cancer</keyword>
</DOC>